Sensex rises 31 pts as banking and healthcare stocks gain

	Dated:14 May,2013

Top Headlines Top investment themes by experts for this year Markets have been on a roll since April 2013, supported by ample liquidity infused by foreign institutional investors. Four reasons why buying into Ranbaxy yet may not be a wise decision For Ranbaxy, the worst may seem to be over with the US settlement. However, it may still not be a wise decision to jump into buying the stock. Sensex rises 31 pts; banking and healthcare stocks gain Sun Pharma at Rs 963.65 was the biggest gainer by rising 2.03 per cent followed by ONGC by 1.78 per cent at Rs 326.50 and Bharti Airtel by 1.78 per cent at Rs 317.20. Views on Stocks/Markets Top ten stocks under-owned by FIIs: BofA-ML Analysts bullish on Tata Steel despite writedown Avoid buying the education stocks: Deven Choksey   Market Round-up SENSEX 19722.29 30.62 NIFTY 5995.40 14.95 S&P500 1,633.77 .00 NASDAQ 3,438.79 .00 USD/INR 54.7773 -.03   IPO/Global Markets Asian shares mixed after US data China posts worst day in 3 wks Nikkei eases in choppy trade Rupee / Gold Re weakens despite easing WPI Gold zooms by Rs 380 'Gold sales to jump 30-40%' More 'Market' News Pipavav allots 1.05 cr shares to Rakesh Jhunjhunwala, others Pipavav had allotted 50,00,000 warrants each to Jhunjhunwala and his wife Rekha Jhunjhunwala, while 5,00,000 warrants were issued to Utpal Sheth. Aptech rallies on buyback plan; up over 40% in May The buyback price is at a premium of over 28 per cent to the CMP. The stock is likely to see some more upmove in the near term, say dealers. Sebi begins repayment process in Sahara case In the high profile Sahara case involving over Rs 24,000 crore raised through "various illegalities", market regulator Sebi has begun the repayment process.